Finoriq research workspace

Axogen, Inc. (AXGN) SEC Filings & Filing Highlights

Axogen, Inc. engages in the development and commercialization of the technologies used for. Review AXGN SEC filings, filing highlights, and disclosure activity on Finoriq.

Company Snapshot

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

Company

Axogen, Inc. (AXGN)

Ticker

AXGN

Market Cap

$2.1B

Latest Price

$39.32

Industry

Medical Devices

Open insider transactions

Axogen, Inc. (AXGN) Recent SEC Filing Highlights

Recent SEC filings, filing events, and disclosure highlights indexed for Axogen, Inc. (AXGN).

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.